Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-29 Purchase | 2021-12-01 11:06 am | Eloxx Pharmaceuticals Inc. | ELOX | Geffken Daniel E. INTERIM CFO | 50,000 | $0.72 | $36,000 | 50,000 (Direct) | View |
| 2021-05-13 Purchase | 2021-05-17 09:22 am | Eloxx Pharmaceuticals Inc. | ELOX | PAREKH RAJESH B Director | 2,466,666 | $1.35 | $3,329,999 | 4,827,129 (Indirect) | View |
| 2021-05-13 Purchase | 2021-05-17 07:03 am | Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (China) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (Israel) IV L.P. Pontifax IV GP L.P. 10% Owner | 5,925,925 | $1.35 | $7,999,999 | 616,592 (Indirect) | View |
| 2021-05-13 Purchase | 2021-05-17 07:02 am | Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director | 5,925,925 | $1.35 | $7,999,999 | 7,804,778 (Indirect) | View |
| 2021-05-13 Purchase | 2021-05-17 07:00 am | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 5,925,925 | $1.35 | $7,999,999 | 7,804,778 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-24 Option Award | 2024-01-26 4:33 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Walts Alan Edmund Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 4:33 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Rubin Steven D Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 4:32 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Androski Lindsay Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 4:32 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit PRESIDENT AND CEO | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-01-30 Option Award | 2023-01-31 4:12 pm | N/A 2033-01-30 | Eloxx Pharmaceuticals Inc. | ELOX | Walts Alan Edmund Director | 2,859 | $0 | 2,859 (Direct) | View |
| 2023-01-30 Option Award | 2023-01-31 4:09 pm | N/A 2033-01-30 | Eloxx Pharmaceuticals Inc. | ELOX | Rubin Steven D Director | 2,859 | $0 | 2,859 (Direct) | View |
| 2023-01-30 Option Award | 2023-01-31 4:08 pm | N/A 2033-01-30 | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 2,859 | $0 | 2,859 (Direct) | View |
| 2023-01-30 Option Award | 2023-01-31 4:07 pm | N/A 2033-01-30 | Eloxx Pharmaceuticals Inc. | ELOX | Androski Lindsay Director | 2,859 | $0 | 2,859 (Direct) | View |
| 2023-01-25 Option Award | 2023-01-27 4:04 pm | N/A 2033-01-25 | Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit PRESIDENT AND CEO | 68,700 | $0 | 68,700 (Direct) | View |
| 2023-01-25 Option Award | 2023-01-27 4:02 pm | N/A 2033-01-25 | Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R&D | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 9:50 pm | N/A 2032-07-01 | Eloxx Pharmaceuticals Inc. | ELOX | Androski Lindsay Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 08:29 am | N/A 2032-06-15 | Eloxx Pharmaceuticals Inc. | ELOX | Walts Alan Edmund Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 08:28 am | N/A 2032-06-15 | Eloxx Pharmaceuticals Inc. | ELOX | Veinrib Gadi Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 08:28 am | N/A 2032-06-15 | Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 08:27 am | N/A 2032-06-15 | Eloxx Pharmaceuticals Inc. | ELOX | Rubin Steven D Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 08:27 am | N/A 2032-06-15 | Eloxx Pharmaceuticals Inc. | ELOX | PAREKH RAJESH B Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 08:26 am | N/A 2032-06-15 | Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 08:24 am | N/A 2032-06-15 | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 08:23 am | N/A 2032-06-15 | Eloxx Pharmaceuticals Inc. | ELOX | Avnur Zafrira Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-03 5:16 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Walts Alan Edmund Director | 37,695 | $0 | 37,695 (Direct) | View |
| 2021-12-01 Tax Withholding | 2021-12-03 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit PRESIDENT AND CEO | 81,933 | $0.72 | 197,225 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-03 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit PRESIDENT AND CEO | 279,158 | $0 | 197,225 (Direct) | View |
| 2021-12-01 Tax Withholding | 2021-12-03 5:14 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R&D | 64,373 | $0.72 | 154,953 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-03 5:14 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R&D | 219,326 | $0 | 154,953 (Direct) | View |
| 2021-07-30 Exercise | 2021-07-30 8:32 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 1,563 | $0 | 42,074 (Direct) | View |
| 2021-07-30 Tax Withholding | 2021-07-30 8:32 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 459 | $1.32 | 42,074 (Direct) | View |
| 2021-05-25 Tax Withholding | 2021-05-26 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 1,835 | $1.39 | 100,345 (Direct) | View |
| 2021-05-25 Exercise | 2021-05-26 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 6,250 | $0 | 100,345 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:11 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Walts Alan Edmund Director | 3,334 | $0 | 3,334 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:11 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | PAREKH RAJESH B Director | 3,334 | $0 | 3,334 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:10 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Avnur Zafrira Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:10 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:10 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:10 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Veinrib Gadi Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:10 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Rubin Steven D Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:10 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-18 5:48 pm | N/A 2031-04-01 | Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R&D | 496,204 | $0 | 496,204 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-18 5:45 pm | N/A 2031-04-01 | Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit PRESIDENT AND CEO | 992,409 | $0 | 992,409 (Direct) | View |